Journal of the American Society of Nephrology, Vol 7, 710-720, Copyright © 1996 by American Society of Nephrology

REGULAR ARTICLES

Effect of recombinant human insulin-like growth factor-1 on the inflammatory response to acute renal injury

N Goes, J Urmson, D Vincent, V Ramassar and PF Halloran
Department of Medicine, University of Alberta, Edmonton, Canada.

Renal ischemic injury evokes an inflammatory response with increased cytokine and major histocompatibility complex (MHC) expression and a mild interstitial infiltrate. This "injury response" could contribute to the tendency of ischemically injured renal transplants to reject. The studies presented here evaluated the ability of recombinant human insulin-like growth factor-1 (rhlGF-1) given after renal injury to prevent renal inflammation. The left renal pedicle of CBA and BALB/c mice was clamped for 60 min, and rhlGF-1 (25, 50, 100 micrograms) was administered sc at 2, 24, 48, 72, and 96 h after reflow. Cytokine and MHC expression was monitored in the injured kidney, compared with the contralateral kidney. In untreated mice, a single episode of injury induced the expression of MHC mRNA and products and tumor necrosis factor-alpha (TNF-alpha) mRNA, and depressed preproepidermal growth factor (ppEGF) mRNA, for up to 5 wk. With immunohistology, epithelial Class I and II MHC expression was shown to be increased for 2 wk, and Class II positive interstitial cells were shown to be increased for up to 5 wk. The ischemically injured kidneys from mice treated with rhlGF- 1 and examined at 5 days showed a dose-dependent normalization of all of the changes of the injury response. This included prevention of the increased expression of MHC and cytokines and the Class II positive interstitial cells, and restoration of ppEGF mRNA. Thus the complex and long-lasting increase in proinflammatory cytokines and MHC expression that follow renal ischemia can be interrupted by treatment with rhlGF-1 beginning 2 h after the injury. This therapy may have applications to the injury response in renal transplants.

This article has been cited by other articles:

				D. Son, I. Kojima, R. Inagi, M. Matsumoto, T. Fujita, and M. Nangaku Chronic hypoxia aggravates renal injury via suppression of Cu/Zn-SOD: a proteomic analysis Am J Physiol Renal Physiol, January 1, 2008; 294(1): F62 - F72. [Abstract] [Full Text] [PDF]

				S. K. Jo, M. H. Rosner, and M. D. Okusa Pharmacologic Treatment of Acute Kidney Injury: Why Drugs Haven't Worked and What Is on the Horizon Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 356 - 365. [Abstract] [Full Text] [PDF]

				W. Dou, S. Thompson-Jaeger, S. J. F. Laulederkind, J. W. Becker, J. Montgomery, E. Ruiz-Bustos, D. L. Hasty, L. R. Ballou, P. S. Eastman, B. Srichai, et al. Defective expression of Tamm-Horsfall protein/uromodulin in COX-2-deficient mice increases their susceptibility to urinary tract infections Am J Physiol Renal Physiol, July 1, 2005; 289(1): F49 - F60. [Abstract] [Full Text] [PDF]

				M. R. Hammerman `The growth hormone–insulin-like growth factor axis in kidney re-revisited Nephrol. Dial. Transplant., August 1, 1999; 14(8): 1853 - 1860. [Full Text] [PDF]

				A. J. van der Lely and W. W. de Herder The Role of Radiotherapy in Acromegaly J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3185 - 3186. [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673